Emerging as a spinoff from Alphabet’s experimental division X, SandboxAQ recently pulled back the curtain on its latest endeavor —  the biopharma molecular simulation division AQBioSim. The venture has attracted investments from significant figures like former Alphabet CEO Eric Schmidt, who is now the chair of Sandbox AQ, and Salesforce.com Inc. founder Marc Benioff’s Time…